• Advertise
  • Contact Us
  • Daily The Business
  • Privacy Policy
Social icon element need JNews Essential plugin to be activated.
Tuesday, May 5, 2026
Daily The Business
  • Login
No Result
View All Result
DTB
No Result
View All Result
DTB

India’s equity benchmarks have a muted end to 2024

January 2, 2025
in Markets
India’s equity benchmarks have a muted end to 2024

Indian benchmark indexes were muted on Tuesday, weighed by a drop in information technology stocks, while elevated U.S. Treasury yields continued to hurt emerging market assets.

The Nifty 50 closed flat at 23,644.8 points, while the BSE Sensex shed 0.14% to 78,139.01. Both the indexes fell about 0.5% earlier in the session.

They gained about 8.5% in 2024, to log a ninth straight annual rise.

Four of the 13 major sectors declined on the day, with IT, down 1.4%, as the top sectoral loser.

The drop in shares of IT companies, which earn a significant share of their revenue from the U.S., comes amid broader market weakness since the Federal Reserve, earlier this month, signalled fewer rate reductions in 2025 than expected earlier.

That pushed Treasury yields higher, making emerging markets such as India less attractive for foreign institutional investors, which have sold about $2.8 billion of Indian shares over the last 10 sessions.

“High U.S. Treasury yields and a stronger dollar have tempted foreign investors to take at least a part of their money from emerging markets like India to the U.S., weighing on domestic equities,” said Krishna Rao, managing director and co-head of equity broking group at JM Financial Services.

Banks lead Indian shares lower as high US Treasury yields weigh

The broader, more domestically focussed smallcaps rose 0.7% while midcaps ended flat.

Other Asian markets fell, with the MSCI Asia ex-Japan index shedding 0.5%.

Among individual stocks, Adani Wilmar declined 6.3% after the Adani group said it would exit the consumer goods joint venture with Singapore’s Wilmar in a $2 billion deal.

The maximum per-share value of the deal was a 7.2% discount to the stock’s close on Monday, which along with uncertainty over how Wilmar will replace the Adani group, led to the drop.

Drug maker Lupin rose 2% to a record high after buying diabetes drug Huminsulin in India from Eli Lilly.

Tags: Indian sharesIndian stocksNSE Nifty 50 indexS&P BSE Sensex
Previous Post

Steady sterling on track for best G10 performance against dollar in 2024

Next Post

Copper eases but heads for second straight yearly rise

American Dollar Exchange Rate
Write us: info@dailythebusiness.com

© 2021 Daily The Business

Social icon element need JNews Essential plugin to be activated.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result

© 2021 Daily The Business

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
Hacklink Satın Al